PuSH - Publication Server of Helmholtz Zentrum München

Lau, H.H.* ; Gan, S.U.* ; Lickert, H. ; Shapiro, A.M.J.* ; Lee, K.O.* ; Teo, A.K.K.*

Charting the next century of insulin replacement with cell and gene therapies.

Med. 2, 1138-1162 (2021)
Publ. Version/Full Text DOI PMC
Free by publisher
The discovery of insulin a century ago changed the lives of millions of individuals suffering from diabetes, paving the way for long-term survival. While the availability of recombinant insulin for hormone replacement therapy has served extremely well to help control blood glucose in diabetes, there remains significant room for further improvements for an ultimate “cure” for diabetes patients. In this review, we celebrate the 100th anniversary of the discovery of insulin and consolidate the key milestones and advances in the development of recombinant human insulin. We then summarize recent and current technological developments in terms of insulin gene- and cell-replacement therapies that are promising in greater therapeutic potential. We envision that the next era of insulin replacement therapies will effectively treat diabetes and serve our patients even better for the next century to come.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
0.000
0.000
1
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Review
Language english
Publication Year 2021
HGF-reported in Year 2021
ISSN (print) / ISBN 2666-6359
e-ISSN 2666-6340
Journal Med (N Y)
Quellenangaben Volume: 2, Issue: 10, Pages: 1138-1162 Article Number: , Supplement: ,
Publisher Cell Press
Reviewing status Peer reviewed
POF-Topic(s) 30201 - Metabolic Health
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-502300-001
Scopus ID 85122725310
PubMed ID 35590204
Erfassungsdatum 2022-01-27